万维提示：
1、投稿方式：在线投稿。
2、官网网址（微信公众号信息）：
https://www.sciencedirect.com/journal/hlife
3、投稿系统：
https://www.editorialmanager.com/hlife/default2.aspx
4、主办单位官网：http://www.im.cas.cn/
5、官网邮箱：hlife@im.ac.cn
6、官网电话：010-64807577
7、出刊日期：月刊，一年出版12期。
8、微信公众号信息：2026年前接收的稿件免收文章处理费（APC）
9、官方微信公众号：hLife Journal
2025年12月3日星期三
Guide for authors
【官网信息】
Introduction
Types of article
The hLife journal publishes full-length original Articles, Reviews, Perspectives, Letters, Commentaries, Resources, Case reports, News & Views, Recollections, Histories, Editorials, and Dialogues.
Article: Original report of a new study in basic, translational, or clinical medicine. It should be organized in the following order: title page, graphical abstract, highlights, abstract, keywords, introduction, results, discussion, materials and methods, acknowledgments, references, figure legends, figures, and tables. With approximately 6000 words in the main text (excluding references and figures/tables); no more than 200 words in the abstract; no less than 6 figures/tables.
Review: Comprehensive and authoritative survey of recent developments and advances in the research field related to health science topics. With graphical abstract and highlights, no less than 8000 words in the main text (excluding references and figures/tables); no more than 200 words in the abstract; no less than 6 figures/tables.
Perspective: Review and discuss the primary research literature in which the authors may express particular points of view about health-related science and social issues. The length of the main text (main text excluding references and figures/tables) should not exceed 1500 words; an abstract is not required; 1 figure/table, and no more than 10 references.
Letter: Original report of timely new results that are of substantial clinical, medical, or public health importance. The length of the main text (main text excluding references and figures/tables) should not exceed 1000 words; an abstract is not required; 1 figure/table, and no more than 10 references.
Commentary: Authors may offer their views or opinions on a specific topic in the field of health science. The length of the main text body (excluding references and figures/tables) should not exceed 1000 words, an abstract is not required; 1 figure/table, and no more than 10 references.
Resource: A technical platform or a large data set of broad utility, interest, and significance to the community. With approximately 6000 words in the main text (excluding references and figures/tables); up to 8 figures/tables.
Case report: Describe no more than three patients or a single family. The length of the main text (including introduction, methods, results, and discussion) should be approximately 5000 words; up to 8 figures/tables.
News & Views: These papers inform nonspecialist readers about new scientific advances or important events related to health sciences. This is a commission-only section. The length of the main text (main text excluding references and figures/tables) should not exceed 1000 words; an abstract is not required; 1 figure, and no more than 5 references.
Recollection: Introducing famous scientists in modern and contemporary history and their contributions to science and medicine. The length of the main text (excluding references and figures/tables) should not exceed 1500 words, up to 1 figure, and no more than 10 references.
History: Focus on historical studies related to the history of science and technology in biology and medicine, with particular emphasis on scientific research and academic impact. The length of the main text (main text excluding references and figures/tables) should not exceed 1500 words, 1 figure/table, and no more than 10 references.
Editorial: Comment and discussion of important aspects of science and medicine, usually interfacing with policy or society; not exceed 1000 words, and no more than 10 references.
Dialogue: Dialogue among the leading scientists or health policymakers on issues that are of interest to the readership of hLife. The length of the main text (main text excluding references and figures/tables) should not exceed 3000 words, 1 figure, and approximately 5 references.
Note: Word limits are provided for guidance only. The Editors will consider submissions that exceed the recommended limit, subject to feedback received during peer review.
Submission checklist
You can use this list to carry out a final check of your submission before you send it to the journal for review. Please check the relevant section in this Guide for Authors for more details.
Ensure that the following items are present:
One author has been designated as the corresponding author with an email address.
All necessary files have been uploaded:
Manuscript
Include keywords
All figures (include relevant captions)
All tables (including titles, description, footnotes)
Ensure all figure and table citations in the text match the files provided; Indicate clearly if color should be used for any figures in print
Graphical Abstracts / Highlights files (where applicable)
Supplemental files (where applicable)
Further considerations:
Manuscript has been 'spell checked' and 'grammar checked'
All references mentioned in the Reference List are cited in the text, and vice versa
Permission has been obtained for use of copyrighted material from other sources (including the Internet)
A competing interests statement is provided, even if the authors have no competing interests to declare
Journal policies detailed in this guide have been reviewed
For further information, visit our Support Center.
Before you begin
Ethics in publishing
Please see our information on Ethics in publishing.
Studies in humans and animals
About studies in humans:
If the work involves the use of human subjects, the author should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. The manuscript should be in line with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals and aim for the inclusion of representative human populations (sex, age and ethnicity) as per those recommendations. The terms sex and gender should be used correctly.
About registration of clinical trials:
Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with the International Committee of Medical Journal Editors recommendations. All clinical trials must be registered before enrollment of the first participant. Trial registration records must be available in a primary register of the WHO International Clinical Trials Registry Platform (ICTRP), in ClinicalTrials.gov, or in any publicly accessible database that meets the minimum 24-item trial registration dataset. The clinical trial registration number is recommended to be stated at the end of the article abstract, in the ethics statement within the main text, and in the ethics approval section. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example, drugs, surgical procedures, devices, behavioral treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.
About clinical trial results:
Authors should fully disclose all postings in registries of results of the same or closely related work. Divulging results in some circumstances (e.g., investors’ meetings) is discouraged and may jeopardise consideration of the manuscript.
About reporting clinical trials:
Authors reporting randomized controlled trials should refer to the CONSORT Statement for recommendations to facilitate the complete and transparent reporting of trial findings. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal, and completion, and a detailed description of the randomization procedure. Reports that do not conform to the CONSORT guidelines may need to be revised before formal review.
Often-used guidelines can be found on the Equator Network website, below is the list, but others may apply. If you cannot find an appropriate guideline here, search the full Equator Network database or contact our editor.
•Randomized controlled trials (RCTs): CONSORT guidelines, flowchart, and checklist
•Systematic reviews and meta-analyses: PRISMA guidelines, flowchart, and checklist
•Observational studies in epidemiology: STROBE guidelines (also refer to RECORD for observational studies using routinely collected health data) and MOOSE guidelines
•Diagnostic accuracy studies: STARD guidelines
•Quality improvement studies: SQUIRE guidelines
•Multivariate prediction models: TRIPOD guidelines
•Economic evaluation studies: CHEERS guidelines
•Animal pre-clinical studies: ARRIVE guidelines
•Web-based surveys: CHERRIES guidelines
•Studies using data from electronic health records: CODE-EHR guidelines
•Reporting of sex and gender information: SAGER guidelines
The author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and have been approved by the appropriate institutional committee(s). This statement should contain the date and reference number of the ethical approval(s) obtained. Authors should also include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
The journal will not accept manuscripts that contain data derived from unethically sourced organs or tissue, including from executed prisoners or prisoners of conscience, consistent with recommendations by Global Rights Compliance on Mitigating Human Rights Risks in Transplantation Medicine. For all studies that use human organs or tissues authors must provide sufficient evidence that they were procured in line with WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation. The source of the organs or tissues used in clinical research must be transparent and traceable. Authors of manuscripts describing organ transplantation must additionally declare within the manuscript:
that autonomous consent free from coercion was obtained from the donor(s) or their next of kin; and
that organs/tissues were not sourced from executed prisoners or prisoners of conscience.
......
更多详情：
https://www.sciencedirect.com/journal/hlife/publish/guide-for-authors
